Blog
RSS FeedPosted by Michael Wonder on 06 Apr 2020
Medicines Australia and the Generic and Biosimilar Medicines Association granted interim authorisation by the ACCC
3 April 2020 - In an important collaborative step, Medicines Australia and the Generic and Biosimilar Medicines Association have today ...
Posted by Michael Wonder on 26 Mar 2020
Novartis and life sciences companies commit expertise and assets to the fight against COVID-19 pandemic alongside Bill & Melinda Gates Foundation
26 March 2020 - Collaboration to address product development and scale up challenges posed by current pandemic. ...
Posted by Michael Wonder on 20 Mar 2020
Coronavirus vindicates capitalism
19 March 2020 - Drug companies will save lives, even as Bernie Sanders is denouncing them. ...
Posted by Michael Wonder on 17 Mar 2020
Generic ‘identity’ gets lost when companies juggle both generic and brand drugs
17 March 2020 - We think we know generic drug companies. They challenge patents held by brand firms. They litigate ...
Posted by Michael Wonder on 15 Mar 2020
Mending the broken social contract for pharmaceutical pricing and innovation
13 March 2020 - The biopharmaceutical industry is under unprecedented assault by the public and politicians. ...
Posted by Michael Wonder on 09 Mar 2020
PhRMA: federal biosimilar payment policies are having a positive effect
4 March 2020 - Katie Verb, director of policy and research for the biopharmaceutical industry group PhRMA, discusses recent policy changes ...
Posted by Michael Wonder on 07 Mar 2020
Is it time to nationalise the pharmaceutical industry?
4 March 2020 - Drug companies fail to take account of the public interest and relentlessly focus on short term returns, ...
Posted by Michael Wonder on 03 Mar 2020
The coronavirus could help pharma reset its reputation in Washington
3 March 2020 - The coronavirus outbreak could be the pharmaceutical industry’s ticket to saving its reputation in Washington. ...
Posted by Michael Wonder on 03 Mar 2020
'Get it done. We need it': Trump's coronavirus message to big pharma
3 March 2020 - President Donald Trump sought to show his personal engagement in the fight against coronavirus, meeting with ...
Posted by Michael Wonder on 19 Feb 2020
How the drug lobby lost its mojo in Washington
19 February 2020 - A rift between the GOP and its longtime pharmaceutical-industry allies is shaking up policy, as Republicans and ...
Posted by Michael Wonder on 06 Feb 2020
Major pharmaceuticals' January drug price hikes were smallest in at least 6 years
5 February 2020 - When major drug makers delivered their customary January price hikes last month, they increased the list ...
Posted by Michael Wonder on 05 Feb 2020
Pharma execs argue new Canadian regulations for setting drug prices will hurt the country
4 February 2020 - As Canada gets set to implement new regulations designed to cut prescription drug spending, the pharmaceutical ...
Posted by Michael Wonder on 23 Jan 2020
Want to know how contentious drug pricing is in Washington? Check the receipts.
23 January 2020 - Pfizer, Johnson & Johnson, Merck, and the 31 other major drug makers that belong to the ...
Posted by Michael Wonder on 22 Jan 2020
Supporting innovative medicines funding in Scotland
21 January 2020 - Scotland receives superb value from the latest medicines and vaccines thanks to robust measures which ensure ...
Posted by Michael Wonder on 21 Jan 2020
Pharma says price regulation will take life saving drugs away from us, but here’s the truth
21 January 2020 - The US isn’t the only country struggling with the high price of prescription drugs. A decade ...